SCHEMBL934784

SCHEMBL934784

Cc1ccccc1-c1ccc(C(=O)O)nc1-c1ccc(Cl)c(C=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 4/20 0.44
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
KMO O15229 1/20 0.37
CNR1 P21554 1/20 0.36
MCL1 Q07820 1/20 0.36
HSD17B14 Q9BPX1 1/20 0.36
FTO Q9C0B1 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GRM2 Q14416 1/20 0.35
ERN1 O75460 1/20 0.35
PPP1CA P62136 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTGER1 P34995 1/20 0.34
PTGER3 P43115 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040384 0.85 EIF4E (0.46) EIF4EKMOCNR1MCL1HSD17B14
SCHEMBL1050097 0.82 EIF4E (0.44) EIF4EKMOCNR1MCL1HSD17B14
SCHEMBL4037851 0.78 PTGER1 (0.47) EIF4EMCL1PTGER1DHODH
SCHEMBL912838 0.75 KDM4E (0.45) EIF4EALDH1A1LMNAMEN1KMT2A
SCHEMBL951541 0.74 HSD17B14 (0.43) EIF4EALDH1A1KMOMCL1HSD17B14
SCHEMBL545109 0.73 HSD17B14 (0.40) EIF4EALDH1A1LMNACNR1MCL1
Hydrochloric Acid SCHEMBL544567 0.73 KDM4E (0.41) EIF4EKMOMCL1
SCHEMBL934656 0.72 CTSA (0.44)
SCHEMBL4041123 0.70 MCL1 (0.46) CNR1MCL1MEN1KMT2ASMN1; SMN2
SCHEMBL544584 0.70 NOTUM (0.51) CNR1MCL1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011007091-A1 DERIVATIVES OF 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS UROTENSIN-II RECEPTOR ANTAGONISTS SANOFI-AVENTIS (FR) 2011-01-20 WO disclosed